Split Biosciences
Facts
- HQ
- Seattle
- Sectors
- Biotech, Life Sciences, Research tools
- Stage
- startup
- Members see funding amounts. .
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Split Biosciences
Parse Biosciences raises $41.5M to scale Evercode single-cell RNA sequencing kits that profile up to 1M cells
Parse Biosciences, a Seattle startup co-founded by CEO Alex Rosenberg and CTO Charles Roco, raised $41.5 million to expand its single-cell RNA sequencing kits and software, which scale to profile up to one million cells using standard lab equipment. The company, launched from University of Washington research, now has more than 300 customers and emphasizes ease of use versus competitors requiring specialized hardware.
Parse Biosciences raises $7M led by Bioeconomy Capital to scale single-cell RNA-seq tech; total funding $9M
Parse Biosciences (formerly Split Biosciences) raised $7 million to grow its single-cell RNA-seq 'Whole Transcriptome Kit' that profiles up to 100,000 cells across 48 samples; the 16-person startup spun out of UW in 2018 and has 40+ labs using its kit.
Questions about Split Biosciences
What is Split Biosciences?
Split Biosciences is a startup headquartered in Seattle.
What has Split Biosciences been in the news for?
GeekWire reported in February 2022 on Parse Biosciences scaling Evercode single-cell RNA sequencing kits. GeekWire reported in January 2021 on Parse Biosciences scaling single-cell RNA-seq technology.
Where is Split Biosciences based?
Split Biosciences is based in Seattle.